NEW YORK (Reuters) - As CVS Health's new CEO David Joyner steps into the top job after Karen Lynch's quick departure on ...

Women have long faced more challenges than men while making their way to the uppermost ranks of prominent companies. And it’s ...

That has been the existential question for CVS Health for six years, since its $70 billion acquisition of the massive insurer ...

As CVS Health's new CEO David Joyner steps into the top job, Wall Street analysts and some investors are questioning whether ...

Pharmacies prescribe big changes, Apple and Nvidia keep tech stocks rally going, canceling subscriptions gets easier ...

In a tight, historically expensive presidential election, both candidates are seeking the support of powerful business ...

While rates, risk adjustment and the IRA are exerting pressure on Medicare Advantage, CVS Health has some "self-induced" ...

Karen Lynch frequently spoke of how her mother's death from suicide and her aunt's death from cancer shaped her health care ...

As the new CEO at CVS, Joyner’s strategic partner will be CFO Tom Cowhey, who was promoted to the role in January after ...

For three years in a row, Karen Lynch was ranked No. 1 on Fortune's Most Powerful Women list. Her job as CEO of CVS Health ...

The Washington Post reports that intense public backlash and a lawsuit led the FDA to reconsider its declaration, made two weeks ago, that the shortage of weight-loss drugs Mounjaro and Zepbound is ...

David Joyner will take over as the company heads in a new direction to stabilize its finances. CVS Health’s reshuffling has ...